CAL-130 Hcl is a novel phosphoinositide 3-kinase (PI3K) inhibitor. It is reported that combined inhibition of PI3K/ as therapy for T cell acute lymphoblastic leukemia (T-ALL).
For research use only. We do not sell to patients.
Name | CAL-130 Hydrochloride |
---|---|
Iupac Chemical Name | (S)-2-(1-((2-amino-9H-purin-6-yl)amino)ethyl)-5-methyl-3-(o-tolyl)quinazolin-4(3H)-one hydrochloride |
Molecular Formula | C23H23ClN8O |
Molecular Weight | 462.93 |
Smile | Cl.NC1=NC(=C2N=CNC2=N1)N[C@@H](C)C1=NC2=CC=CC(=C2C(N1C1=C(C=CC=C1)C)=O)C |
InChiKey | XEUIGTXAJSGCRB-UQKRIMTDSA-N |
InChi | InChI=1S/C23H22N8O.ClH/c1-12-7-4-5-10-16(12)31-21(28-15-9-6-8-13(2)17(15)22(31)32)14(3)27-20-18-19(26-11-25-18)29-23(24)30-20;/h4-11,14H,1-3H3,(H4,24,25,26,27,29,30);1H/t14-;/m0./s1 |
CAS Number | 1431697-78-7 |
Related CAS |
Packaging | Price | Availability | Purity | Shipping Time |
---|---|---|---|---|
Bulk | Enquiry | Enquiry | Enquiry |
Formulation | crystalline solid |
---|---|
Purity | 98% |
Storage | 3 years -20ºCpowder |
Solubility | Soluble in DMSO |
Handling | |
Shipping Condition | Shipped under ambient temperature as non-hazardous chemical. |
HS Code |
Targets | |
---|---|
Mechanism | |
Cell study | |
Animal study | |
Clinical study |